You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 278 No. 23, December 17, 1997 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial

F. L. Brancati, P. K. Whelton, B. L. Randall, J. D. Neaton, J. Stamler and M. J. Klag
Department of Medicine, The Johns Hopkins Medical Institutions, Baltimore, Md, USA. fbrancat@welchlink.welch.jhu.edu

CONTEXT: Diabetes is a frequent cause of end-stage renal disease (ESRD). However, the degree of risk is uncertain. OBJECTIVE: To determine the relative risk (RR) of ESRD related to diabetes in the United States. DESIGN: Nonconcurrent prospective cohort study. PARTICIPANTS: A total of 332544 men aged 35 to 57 years from 18 US cities screened in 1973 to 1975 for participation in the Multiple Risk Factor Intervention Trial (MRFIT). MAIN EXPOSURE: Diabetes mellitus defined by self-reported use of medication for diabetes at baseline. MAIN OUTCOME: Incident ESRD through 1990 assessed from a national ESRD registry and by surveillance for death from renal disease. RESULTS: Over an average follow-up of 16 years, there were 136 cases of ESRD in 5147 diabetic men and 678 cases in 327397 nondiabetic men. Age-adjusted incidence of all-cause ESRD in the diabetic men was 199.8 per 100000 person-years compared with 13.7 per 100000 person years in their nondiabetic counterparts (RR, 12.7; 95% confidence interval [CI], 10.5-15.4). Diabetic men were also at higher risk for ESRD ascribed to causes other than diabetes (RR=4.3; 95% CI, 3.2-5.9). With simultaneous adjustment for age, ethnicity, income, blood pressure, serum cholesterol level, and history of myocardial infarction, diabetic men remained at higher risk for all-cause ESRD (RR, 9.0; 95% CI, 7.4-11.0), ESRD ascribed to diabetes (RR, 92.3; 95% CI, 64.6-131.9), and ESRD ascribed to nondiabetic causes (RR, 3.0; 95% CI, 2.2-4.1). CONCLUSIONS: Diabetes mellitus is a strong independent risk factor for ESRD, even for ESRD ascribed to causes other than diabetes. Improvements in the prevention and control of diabetes should produce substantial reductions in ESRD incidence.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Trends in Diabetes, High Cholesterol, and Hypertension in Chronic Kidney Disease Among U.S. Adults: 1988-1994 to 1999-2004
Fox and Muntner
Diabetes Care 2008;31:1337-1342.
ABSTRACT | FULL TEXT  

Vildagliptin, a Novel Dipeptidyl Peptidase IV Inhibitor, Has No Pharmacokinetic Interactions With the Antihypertensive Agents Amlodipine, Valsartan, and Ramipril in Healthy Subjects
He et al.
J Clin Pharmacol 2008;48:85-95.
ABSTRACT | FULL TEXT  

Age Affects Outcomes in Chronic Kidney Disease
O'Hare et al.
J. Am. Soc. Nephrol. 2007;18:2758-2765.
ABSTRACT | FULL TEXT  

Are Patients Who Have Metabolic Syndrome without Diabetes at Risk for Developing Chronic Kidney Disease? Evidence Based on Data from a Large Cohort Screening Population
Rashidi et al.
CJASN 2007;2:976-983.
ABSTRACT | FULL TEXT  

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Authors/Task Force Members et al.
Eur Heart J Suppl 2007;9:C3-C74.
FULL TEXT  

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Authors/Task Force Members et al.
Eur Heart J 2007;28:88-136.
FULL TEXT  

Exploring Secular Trends in the Likelihood of Receiving Treatment for End-Stage Renal Disease
Hsu et al.
CJASN 2007;2:81-88.
ABSTRACT | FULL TEXT  

Survival After Heart Transplantation Is Not Diminished Among Recipients With Uncomplicated Diabetes Mellitus: An Analysis of the United Network of Organ Sharing Database
Russo et al.
Circulation 2006;114:2280-2287.
ABSTRACT | FULL TEXT  

The Association among Smoking, Heavy Drinking, and Chronic Kidney Disease
Shankar et al.
Am J Epidemiol 2006;164:263-271.
ABSTRACT | FULL TEXT  

Obesity and Risk for Chronic Renal Failure
Ejerblad et al.
J. Am. Soc. Nephrol. 2006;17:1695-1702.
ABSTRACT | FULL TEXT  

Association of Single Measurements of Dipstick Proteinuria, Estimated Glomerular Filtration Rate, and Hematocrit with 25-Year Incidence of End-Stage Renal Disease in the Multiple Risk Factor Intervention Trial
Ishani et al.
J. Am. Soc. Nephrol. 2006;17:1444-1452.
ABSTRACT | FULL TEXT  

Direct, Progressive Association of Cardiovascular Risk Factors With Incident Proteinuria: Results From the Korea Medical Insurance Corporation (KMIC) Study
Jee et al.
Arch Intern Med 2005;165:2299-2304.
ABSTRACT | FULL TEXT  

Glycemic Status and Development of Kidney Disease: The Framingham Heart Study
Fox et al.
Diabetes Care 2005;28:2436-2440.
ABSTRACT | FULL TEXT  

Low Ankle-Brachial Index Associated With Rise in Creatinine Level Over Time: Results From the Atherosclerosis Risk in Communities Study
O'Hare et al.
Arch Intern Med 2005;165:1481-1485.
ABSTRACT | FULL TEXT  

Metabolic Syndrome and the Risk for Chronic Kidney Disease among Nondiabetic Adults
Kurella et al.
J. Am. Soc. Nephrol. 2005;16:2134-2140.
ABSTRACT | FULL TEXT  

Clinical Outcomes in Antihypertensive Treatment of Type 2 Diabetes, Impaired Fasting Glucose Concentration, and Normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Whelton et al.
Arch Intern Med 2005;165:1401-1409.
ABSTRACT | FULL TEXT  

Elevated Blood Pressure and Risk of End-stage Renal Disease in Subjects Without Baseline Kidney Disease
Hsu et al.
Arch Intern Med 2005;165:923-928.
ABSTRACT | FULL TEXT  

Racial and Ethnic Differences in Microalbuminuria Prevalence in a Diabetes Population: The Pathways Study
Young et al.
J. Am. Soc. Nephrol. 2005;16:219-228.
ABSTRACT | FULL TEXT  

The growing volume of diabetes-related dialysis: a population based study
Lok et al.
Nephrol Dial Transplant 2004;19:3098-3103.
ABSTRACT | FULL TEXT  

Diabetes Is the Strongest Risk Factor for Lower-Extremity Amputation in New Hemodialysis Patients
Speckman et al.
Diabetes Care 2004;27:2198-2203.
ABSTRACT | FULL TEXT  

Predictors of New-Onset Kidney Disease in a Community-Based Population
Fox et al.
JAMA 2004;291:844-850.
ABSTRACT | FULL TEXT  

Racial Differences in Early-Onset Renal Disease among Young Adults: The Coronary Artery Risk Development in Young Adults (CARDIA) Study
Stehman-Breen et al.
J. Am. Soc. Nephrol. 2003;14:2352-2357.
ABSTRACT | FULL TEXT  

Racial Differences in Diabetic Nephropathy, Cardiovascular Disease, and Mortality in a National Population of Veterans
Young et al.
Diabetes Care 2003;26:2392-2399.
ABSTRACT | FULL TEXT  

Progression of Chronic Renal Failure
Yu
Arch Intern Med 2003;163:1417-1429.
ABSTRACT | FULL TEXT  

The Contribution of Increased Diabetes Prevalence and Improved Myocardial Infarction and Stroke Survival to the Increase in Treated End-Stage Renal Disease
Muntner et al.
J. Am. Soc. Nephrol. 2003;14:1568-1577.
ABSTRACT | FULL TEXT  

Epidemic of Diabetic and Nondiabetic Renal Disease among the Zuni Indians: The Zuni Kidney Project
Shah et al.
J. Am. Soc. Nephrol. 2003;14:1320-1329.
ABSTRACT | FULL TEXT  

Resistance to Glomerulosclerosis in B6 Mice Disappears after Menopause
Zheng et al.
Am. J. Pathol. 2003;162:1339-1348.
ABSTRACT | FULL TEXT  

Insulin Resistance and Risk of Chronic Kidney Disease in Nondiabetic US Adults
Chen et al.
J. Am. Soc. Nephrol. 2003;14:469-477.
ABSTRACT | FULL TEXT  

A Diabetes Outcome Progression Trial (ADOPT): An international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes
Viberti et al.
Diabetes Care 2002;25:1737-1743.
ABSTRACT | FULL TEXT  

The role of genetic susceptibility in diabetic nephropathy: evidence from family studies
Fava and Hattersley
Nephrol Dial Transplant 2002;17:1543-1546.
FULL TEXT  

Excess Risk of Chronic Kidney Disease among African-American versus White Subjects in the United States: A Population-Based Study of Potential Explanatory Factors
Tarver-Carr et al.
J. Am. Soc. Nephrol. 2002;13:2363-2370.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.